{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T12:20:56Z","timestamp":1785241256636,"version":"3.55.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"25","license":[{"start":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T00:00:00Z","timestamp":1652140800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T00:00:00Z","timestamp":1652140800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Gouvernement du Canada | Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["CIHR-FDN-148373"],"award-info":[{"award-number":["CIHR-FDN-148373"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2022,6,17]]},"DOI":"10.1038\/s41388-022-02323-9","type":"journal-article","created":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T10:02:54Z","timestamp":1652176974000},"page":"3445-3451","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Physiological expression of PI3K H1047R mutation reveals its anti-metastatic potential in ErbB2-driven breast cancer"],"prefix":"10.1038","volume":"41","author":[{"given":"Alexandra M.","family":"Simond","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tung","family":"Bui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongmei","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Sanguin-Gendreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trisha","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7961-638X","authenticated-orcid":false,"given":"Wayne A.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert D.","family":"Cardiff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7293-4166","authenticated-orcid":false,"given":"William J.","family":"Muller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,10]]},"reference":[{"key":"2323_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394\u2013424.","journal-title":"CA Cancer J Clin"},{"key":"2323_CR2","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/bs.acr.2020.04.004","volume":"147","author":"AM Simond","year":"2020","unstructured":"Simond AM, Muller WJ. In vivo modeling of the EGFR family in breast cancer progression and therapeutic approaches. Adv Cancer Res. 2020;147:189\u2013228.","journal-title":"Adv Cancer Res"},{"key":"2323_CR3","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/S0092-8674(00)80696-0","volume":"100","author":"MP Czech","year":"2000","unstructured":"Czech MP. PIP2 and PIP3: complex roles at the cell surface. Cell. 2000;100:603\u20136.","journal-title":"Cell"},{"key":"2323_CR4","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1146\/annurev.cellbio.17.1.615","volume":"17","author":"R Katso","year":"2001","unstructured":"Katso R, Okkenhaug K, Ahmadi K, White S, Timms J, Waterfield MD. Cellular function of phosphoinositide 3-kinases: implications for development, homeostasis, and cancer. Annu Rev Cell Dev Biol. 2001;17:615\u201375.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"2323_CR5","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1006\/excr.1999.4701","volume":"253","author":"B Vanhaesebroeck","year":"1999","unstructured":"Vanhaesebroeck B, Waterfield MD. Signaling by distinct classes of phosphoinositide 3-kinases. Exp Cell Res. 1999;253:239\u201354.","journal-title":"Exp Cell Res"},{"key":"2323_CR6","doi-asserted-by":"publisher","first-page":"19704","DOI":"10.1016\/S0021-9258(17)45429-9","volume":"265","author":"CL Carpenter","year":"1990","unstructured":"Carpenter CL, Duckworth BC, Auger KR, Cohen B, Schaffhausen BS, Cantley LC. Purification and characterization of phosphoinositide 3-kinase from rat liver. J Biol Chem. 1990;265:19704\u201311.","journal-title":"J Biol Chem"},{"key":"2323_CR7","doi-asserted-by":"publisher","first-page":"19236","DOI":"10.1074\/jbc.272.31.19236","volume":"272","author":"D Chantry","year":"1997","unstructured":"Chantry D, Vojtek A, Kashishian A, Holtzman DA, Wood C, Gray PW, et al. p110delta, a novel phosphatidylinositol 3-kinase catalytic subunit that associates with p85 and is expressed predominantly in leukocytes. J Biol Chem. 1997;272:19236\u201341.","journal-title":"J Biol Chem"},{"key":"2323_CR8","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/0092-8674(92)90166-A","volume":"70","author":"ID Hiles","year":"1992","unstructured":"Hiles ID, Otsu M, Volinia S, Fry MJ, Gout I, Dhand R, et al. Phosphatidylinositol 3-kinase: structure and expression of the 110 kd catalytic subunit. Cell. 1992;70:419\u201329.","journal-title":"Cell"},{"key":"2323_CR9","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1200\/JCO.1998.16.4.1340","volume":"16","author":"IL Andrulis","year":"1998","unstructured":"Andrulis IL, Bull SB, Blackstein ME, Sutherland D, Mak C, Sidlofsky S, et al. neu\/erbB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer. Toronto Breast Cancer Study Group. J Clin Oncol. 1998;16:1340\u20139.","journal-title":"J Clin Oncol"},{"key":"2323_CR10","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1038\/nrd4204","volume":"13","author":"DA Fruman","year":"2014","unstructured":"Fruman DA, Rommel C. PI3K and cancer: lessons, challenges and opportunities. Nat Rev Drug Disco. 2014;13:140\u201356.","journal-title":"Nat Rev Drug Disco"},{"key":"2323_CR11","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1126\/science.1150799","volume":"318","author":"CH Huang","year":"2007","unstructured":"Huang CH, Mandelker D, Schmidt-Kittler O, Samuels Y, Velculescu VE, Kinzler KW, et al. The structure of a human p110alpha\/p85alpha complex elucidates the effects of oncogenic PI3Kalpha mutations. Science. 2007;318:1744\u20138.","journal-title":"Science"},{"key":"2323_CR12","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1126\/science.1135394","volume":"317","author":"N Miled","year":"2007","unstructured":"Miled N, Yan Y, Hon WC, Perisic O, Zvelebil M, Inbar Y, et al. Mechanism of two classes of cancer mutations in the phosphoinositide 3-kinase catalytic subunit. Science. 2007;317:239\u201342.","journal-title":"Science"},{"key":"2323_CR13","doi-asserted-by":"publisher","first-page":"5486","DOI":"10.1038\/onc.2008.244","volume":"27","author":"L Zhao","year":"2008","unstructured":"Zhao L, Vogt PK. Class I PI3K in oncogenic cellular transformation. Oncogene. 2008;27:5486\u201396.","journal-title":"Oncogene"},{"key":"2323_CR14","doi-asserted-by":"publisher","first-page":"6064","DOI":"10.1158\/1078-0432.CCR-07-0266","volume":"13","author":"M Barbareschi","year":"2007","unstructured":"Barbareschi M, Buttitta F, Felicioni L, Cotrupi S, Barassi F, Del Grammastro M, et al. Different prognostic roles of mutations in the helical and kinase domains of the PIK3CA gene in breast carcinomas. Clin Cancer Res. 2007;13:6064\u20139.","journal-title":"Clin Cancer Res"},{"key":"2323_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/bcr3113","volume":"14","author":"M Cizkova","year":"2012","unstructured":"Cizkova M, Susini A, Vacher S, Cizeron-Clairac G, Andrieu C, Driouch K, et al. PIK3CA mutation impact on survival in breast cancer patients and in ERalpha, PR and ERBB2-based subgroups. Breast Cancer Res. 2012;14:R28.","journal-title":"Breast Cancer Res"},{"key":"2323_CR16","doi-asserted-by":"publisher","first-page":"327","DOI":"10.5732\/cjc.012.10032","volume":"31","author":"AG Dumont","year":"2012","unstructured":"Dumont AG, Dumont SN, Trent JC. The favorable impact of PIK3CA mutations on survival: an analysis of 2587 patients with breast cancer. Chin J Cancer. 2012;31:327\u201334.","journal-title":"Chin J Cancer"},{"key":"2323_CR17","doi-asserted-by":"publisher","first-page":"2558","DOI":"10.1111\/cas.13696","volume":"109","author":"T Shimoi","year":"2018","unstructured":"Shimoi T, Hamada A, Yamagishi M, Hirai M, Yoshida M, Nishikawa T, et al. PIK3CA mutation profiling in patients with breast cancer, using a highly sensitive detection system. Cancer Sci. 2018;109:2558\u201366.","journal-title":"Cancer Sci"},{"key":"2323_CR18","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1038\/bjc.2013.164","volume":"108","author":"M Cizkova","year":"2013","unstructured":"Cizkova M, Dujaric ME, Lehmann-Che J, Scott V, Tembo O, Asselain B, et al. Outcome impact of PIK3CA mutations in HER2-positive breast cancer patients treated with trastuzumab. Br J Cancer. 2013;108:1807\u20139.","journal-title":"Br J Cancer"},{"key":"2323_CR19","doi-asserted-by":"publisher","first-page":"9221","DOI":"10.1158\/0008-5472.CAN-08-1740","volume":"68","author":"PJ Eichhorn","year":"2008","unstructured":"Eichhorn PJ, Gili M, Scaltriti M, Serra V, Guzman M, Nijkamp W, et al. Phosphatidylinositol 3-kinase hyperactivation results in lapatinib resistance that is reversed by the mTOR\/phosphatidylinositol 3-kinase inhibitor NVP-BEZ235. Cancer Res. 2008;68:9221\u201330.","journal-title":"Cancer Res"},{"key":"2323_CR20","doi-asserted-by":"publisher","first-page":"3444","DOI":"10.1073\/pnas.97.7.3444","volume":"97","author":"ER Andrechek","year":"2000","unstructured":"Andrechek ER, Hardy WR, Siegel PM, Rudnicki MA, Cardiff RD, Muller WJ. Amplification of the neu\/erbB-2 oncogene in a mouse model of mammary tumorigenesis. Proc Natl Acad Sci USA. 2000;97:3444\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2323_CR21","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1172\/JCI59309","volume":"122","author":"KM Kinross","year":"2012","unstructured":"Kinross KM, Montgomery KG, Kleinschmidt M, Waring P, Ivetac I, Tikoo A, et al. An activating Pik3ca mutation coupled with Pten loss is sufficient to initiate ovarian tumorigenesis in mice. J Clin Invest. 2012;122:553\u20137.","journal-title":"J Clin Invest"},{"key":"2323_CR22","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2:401\u20134.","journal-title":"Cancer Discov"},{"key":"2323_CR23","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013;6:pl1.","journal-title":"Sci Signal"},{"key":"2323_CR24","doi-asserted-by":"publisher","first-page":"226","DOI":"10.2741\/3617","volume":"15","author":"PR Pandey","year":"2010","unstructured":"Pandey PR, Saidou J, Watabe K. Role of myoepithelial cells in breast tumor progression. Front Biosci (Landmark Ed). 2010;15:226\u201336.","journal-title":"Front Biosci (Landmark Ed)"},{"key":"2323_CR25","doi-asserted-by":"publisher","first-page":"46785","DOI":"10.18632\/oncotarget.8800","volume":"7","author":"YR Li","year":"2016","unstructured":"Li YR, Yang WX. Myosins as fundamental components during tumorigenesis: diverse and indispensable. Oncotarget. 2016;7:46785\u2013812.","journal-title":"Oncotarget"},{"key":"2323_CR26","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.1111\/febs.12175","volume":"280","author":"S Koren","year":"2013","unstructured":"Koren S, Bentires-Alj M. Mouse models of PIK3CA mutations: one mutation initiates heterogeneous mammary tumors. FEBS J. 2013;280:2758\u201365.","journal-title":"FEBS J"},{"key":"2323_CR27","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.1158\/0008-5472.CAN-10-0738","volume":"71","author":"JR Adams","year":"2011","unstructured":"Adams JR, Xu K, Liu JC, Agamez NM, Loch AJ, Wong RG, et al. Cooperation between Pik3ca and p53 mutations in mouse mammary tumor formation. Cancer Res. 2011;71:2706\u201317.","journal-title":"Cancer Res"},{"key":"2323_CR28","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/ng1963","volume":"39","author":"SG Julien","year":"2007","unstructured":"Julien SG, Dube N, Read M, Penney J, Paquet M, Han Y, et al. Protein tyrosine phosphatase 1B deficiency or inhibition delays ErbB2-induced mammary tumorigenesis and protects from lung metastasis. Nat Genet. 2007;39:338\u201346.","journal-title":"Nat Genet"},{"key":"2323_CR29","doi-asserted-by":"publisher","first-page":"4344","DOI":"10.1158\/0008-5472.CAN-10-3827","volume":"71","author":"DS Meyer","year":"2011","unstructured":"Meyer DS, Brinkhaus H, Muller U, Muller M, Cardiff RD, Bentires-Alj M. Luminal expression of PIK3CA mutant H1047R in the mammary gland induces heterogeneous tumors. Cancer Res. 2011;71:4344\u201351.","journal-title":"Cancer Res"},{"key":"2323_CR30","first-page":"999","volume":"8","author":"BR Davies","year":"1993","unstructured":"Davies BR, Davies MP, Gibbs FE, Barraclough R, Rudland PS. Induction of the metastatic phenotype by transfection of a benign rat mammary epithelial cell line with the gene for p9Ka, a rat calcium-binding protein, but not with the oncogene EJ-ras-1. Oncogene. 1993;8:999\u20131008.","journal-title":"Oncogene"},{"key":"2323_CR31","doi-asserted-by":"publisher","first-page":"5049","DOI":"10.1158\/1078-0432.CCR-09-0632","volume":"15","author":"K Kalinsky","year":"2009","unstructured":"Kalinsky K, Jacks LM, Heguy A, Patil S, Drobnjak M, Bhanot UK, et al. PIK3CA mutation associates with improved outcome in breast cancer. Clin Cancer Res. 2009;15:5049\u201359.","journal-title":"Clin Cancer Res"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-022-02323-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-022-02323-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-022-02323-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T03:29:34Z","timestamp":1655436574000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-022-02323-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,10]]},"references-count":31,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2022,6,17]]}},"alternative-id":["2323"],"URL":"https:\/\/doi.org\/10.1038\/s41388-022-02323-9","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,10]]},"assertion":[{"value":"7 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}